Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

S1RA shows promise as analgesic for neuropathic pain

June 25, 2010

Sorafenib exhibits antitumor activity in hematological malignancies in phase I trial

June 25, 2010

CAT-8015 is evaluated in phase I trial in hairy cell leukemia

June 23, 2010

TH-302/doxorubicin combination is safe in phase I/II trial in soft tissue sarcoma

June 23, 2010

Phase II data support use of florbetaben to diagnose AD using PET

June 23, 2010

IMB-007 shows promise as neuropathic pain therapy

June 23, 2010

TC-5214 shows benefit as add-on to citalopram in major depression

June 23, 2010

Synergy seen with topiramate and amantadine in model of levodopa-induced dyskinesia

June 23, 2010

ALD-518 improves rheumatoid arthritis symptoms in phase II trial

June 22, 2010

177Lu-J591 shows safety and preliminary efficacy in metastatic CRPC

June 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...